(Date:2/8/2010)... surface for label-free biomolecular interaction analysis now offers surface ... Protein A and Protein G for coupling antibodies. ... ... CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., ... the world,s first 3D biosensor surface for label-free biomolecular ...
(Date:2/8/2010)... and NEW ORLEANS , Feb. 8 ... a worldwide developer and marketer of diagnostic test kits, ... extension of the collaborative effort to combat viral hemorrhagic ... $800,000 in contract revenue for Corgenix over ... Institutes of Health (NIH) has awarded a five-year contract ...
(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...
(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- ... "the Company"), a leading China -based ... marketing,biopharmaceutical products, today announced a collaboration and ... and commercialize its,Nephoxil(R) pharmaceutical product for the ... Nephoxil (ferric citrate) ...
Breaking Biology Technology:Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 43SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4... Murray Grossan, MD (creator of the Hydro-Pulse sinus irrigation ... anti-fungals and anti-inflammatories directly into the sinus cavities using ... helpful for his patients who experience symptoms of sinus ... ...
... 30 Nektar,Therapeutics (Nasdaq: NKTR ) will announce ... 2008 on Wednesday, August 6, 2008, after the,close of ... will host a conference call to review the results,beginning ... (PT)., The press release and a live audio-only ...
... SAN DIEGO, July 30 Anadys Pharmaceuticals,Inc. (Nasdaq: ... care by developing novel medicines in the areas of,hepatitis ... for the second quarter ended June 30, 2008., ... productive time at,Anadys," said Steve Worland, Ph.D., President and ...
Other Biology Technology:Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation 2Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets 2Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 7(Date:2/9/2010)... the Hood Center for Children and Families at Dartmouth ... on the significant potential negative impact that food product ... , The study, which appears in the current edition ... of the "brand placements" for food, beverage, and food ... for energy-dense, nutrient-poor foods or product lines. In addition, ...
(Date:2/9/2010)... The Scripps Research Institute have discovered a potential new ... for sheep and cattle infected with liver fluke. The ... in combating river blindness, a tropical disease that is ... humans. , The study is scheduled for publication ... Proceedings of the National Academy of Sciences ...
(Date:2/9/2010)... they say is a strong candidate for involvement in ... the natural flux in hormones during the menstrual cycle. ... of the National Academy of Sciences , Rockefeller University ... human variant of the gene increases anxiety, dampens curiosity ... impairing memory. If applied in the clinic, the work ...
Breaking Biology News(10 mins):New study examines the impact on children of food product placements in the movies 2New study examines the impact on children of food product placements in the movies 3Scripps research team reveals how an old drug could have a new use for treating river blindness 2Scripps research team reveals how an old drug could have a new use for treating river blindness 3Scripps research team reveals how an old drug could have a new use for treating river blindness 4Research identifies gene with likely role in premenstrual disorder 2Research identifies gene with likely role in premenstrual disorder 3GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 63059 1GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 63059 2West Coast Banks Salem Battle Creek Branch is Collecting Teddy Bears for Sick Children at the Salem Hospital 63054 1Successful Stem Cell Therapy for Treatment of Eye Disease 15140 1Successful Stem Cell Therapy for Treatment of Eye Disease 15140 2Successful Stem Cell Therapy for Treatment of Eye Disease 15140 3Successful Stem Cell Therapy for Treatment of Eye Disease 15140 4... LC Sciences provides a genome-wide microRNA (miRNA) ... proprietary probe design, which enable highly sensitive ... We have standard arrays for mature miRNA ... version of the Sanger miRBase database (Release ...
... studies, vaccine development, and biosensor development ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive Epitope Peptide Microarray Service. ... Probe content is completely customer specified. ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
... first time, you can identify and characterize ... without interferences. The Agilent Multiple Affinity Removal ... high-abundant proteins from human serum, plasma, CSF ... device. With this revolutionary system, you can: ...
Biology Products:Biology NavigationMedical Navigation